Article information
Full text is only aviable in PDF
Bibliografia
[1.]
J. Turiaf, C.J. Johns, A.S. Teirstein, S. Tsuji, K. Wurm.
The problem of the treatment of sarcoidosis: Report of the subcommittee on therapy.
Seven International Conference on Sarcoidosis and other granulomatous disorders, pp. 743-751
[2.]
R.A. De Remee.
Estimation of granulomatous activity in sarcoidosis: its relevance to course and treatment.
En: Sarcoidosis Japan Medical Research Foundation ed. Publication n.° 13, University of Tokyo Press, (1981), pp. 315-325
[3.]
J.L. Johnson, M.E. Kleinhenz.
Interleukin-2 dysregulation in circulating mononuclear cells of patient with active sarcoidosis. Sarcoidosis and other granulomatous disorders.
pp. 97-100
[4.]
T. Van Maarsseveen, H. Mullink, M. De Haan, J. Stam, J. De Groot.
Prednisolone treatment and alveolar lymphocyte-macro-phage cooperation in sarcoidosis. Sarcoidosis and other granulomatous disorders.
pp. 101-104
[5.]
A. Blasi.
Pathology from granuloma to fibrosis: Outlook. Sarcoidosis and other granulomatous disorders.
pp. 273-275
[6.]
M. Luisetti, C. Aprile, L. Bacchella, et al.
Elevation of serum type III procollagen N-terminal peptide levels in thoracic sarcoidosis: A possible index for fibroblast activity. Sarcoidosis and other granulomatous disorders.
pp. 563-566
[7.]
O. Refvem, O.K. Refvem.
Long term corticosteroid treatment of pulmonary sarcoidosis. Eighth International Conference on sarcoidosis and other granulomatous diseases.
pp. 648-651
[8.]
M. Turner-Warwick.
Treatment of pulmonary sarcoidosis.
State of the art. Sarcoidosis and other granulomatous disorders, pp. 621-629
[9.]
R.L. Young, L.E. Harkleroad, R.E. London, J.G. Weg.
Pulmonary sarcoidosis: A prospective evaluation of glucocorticoid therapy.
Ann Intern Med, 73 (1970), pp. 207-212
[10.]
H.L. Israel, D.W. Fouts, R.A. Beggs.
A controlled trial of prednisone treatment of sarcoidosis.
Am Rev Respir Dis, 107 (1973), pp. 609-614
[11.]
R.A. De Remee.
The present status of treatment of pulmonary sarcoidosis: A house divided.
Chest, 71 (1977), pp. 388-393
[12.]
L.E. Harkleroad, R.L. Young, P.J. Savage, D.W. Jenkins, R.E. London.
Pulmonary sarcoidosis: Long-term follow-up of the effects of steroid therapy.
Chest, 82 (1982), pp. 84-87
[13.]
C.H. Colp, S.S. Park, M.H. Williams Jr..
Pulmonary function follow-up of 120 patients with sarcoidosis. Seventh International Conference on sarcoidosis and other granulomatous disorders.
pp. 301-307
[14.]
W.G. Middleton, A.C. Douglas.
Prolonged corticosteroid therapy in pulmonary sarcoidosis. Eighth International Conference on sarcoidosis and other granulomatous disease.
pp. 632-647
[15.]
A. Deremee, A.R. Zinsmeister.
State of the art; The treatment of pulmonary sarcoidosis: The present State of the art. Ninth International Conference on sarcoidosis and other granulomatous disorders.
pp. 457-464
[16.]
O.B. Selroos.
Use of budesonide in the treatment of pulmonary sarcoidosis. Tenth International Conference on sarcoidosis and other granulomatous disorders.
pp. 713-721
[17.]
M. Turner-Warwick, P.L. Haslam, W. Mc Allister, A. Britton, R. Lawrence.
Do measurements of bronchoalveolar lymphocytes and neutrophils, serum angiotensin-converting enzyme and Gallium uptake help the clinician to treat patients with sarcoidosis?.
Tenth International Conference on sarcoidosis and other granulomatous disorders, pp. 387-394
[18.]
H. Klech.
Clinical risk assesment in sarcoidosis. Outlook. Sarcoidosis and other granulomatous disorders.
pp. 461-482
[19.]
U. Costabel, K.J. Bross, J. Guzman, A. Nilles, K.H. Rühle, H. Matthys.
Predictive value of bronchoalveoíar T cells subsets for the course of pulmonary sarcoidosis. Tenth International Conference on sarcoidosis and other granulomatous disorders.
pp. 418-426
[20.]
K. Shima, S. Takenaka, S. Higuchi, S. Ikeda, H. Shono, H. Tokuomi.
Monocyte-T-lymphocyte interaction in sarcoidosis patients: clinical use for sarcoidosis activity and therapy. Ninth International Conference on sarcoidosis and other granulomatous disorders.
pp. 150-155
[21.]
B. Campbell, P. Kataria.
Regulation of inflammation by the granuloma of sarcoidosis: Effect of corticosteroids in vitro. Ninth International Conference on sarcoidosis and other granulomatous disorders.
pp. 121-125
[22.]
P. Pinkston, P.B. Bitterman, R.A. Keogh, R.G. Crystal.
In vivo corticosteroid modulation of lung T-cell interleukin-e release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis.
J Immunol, 139 (1987), pp. 755-760
[23.]
P. Pinkston, C. Saltini, J. Mueller-Quernheim, R.G. Crystal.
Corticosteroid therapy suppresses spontaneous inteleukin-2 release. and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis.
J Immunol, 139 (1987), pp. 755-760
[24.]
R. Pérez, G. Staton, M. Kidd.
Increased procoagulant activity of bronchoalveoíar lavage cells in patients with sarcoidosis: relationship to steroid treatment, forced vital capacity, gallium uptake and bronchoalveoíar lavage percent lymphocytes. Sarcoidosis and other granulomatous disorders.
pp. 583
[25.]
M. Spatafora, A. Mirabella, A. Bonanno, et al.
Supression of local immunoglobulin production in active pulmonary sarcoidosis by oral prednisone therapy. Sarcoidosis and other granulomatous disorders.
pp. 191-192
[26.]
M. Sones, H.L. Israel, M.B. Dratman, J.H. Frank.
Effect of cortisone in sarcoidosis.
N Engl J Med, 244 (1951), pp. 200-213
[27.]
L.E. Siltzbach.
Effects of cortisone in sarcoidosis: A study of 13 patients.
Am J Med, 12 (1952), pp. 139-160
[28.]
G.M. Smellie Apthorp, R. Marshall.
The effect of corticosteroid treatment on pulmonary function in sarcoidosis.
Thorax, 16 (1961), pp. 87
[29.]
D.G. James, J.M. Trowell, L.S. Carstairs.
Treatment of sarcoidosis: controlled therapeutic trial.
Lancet, 2 (1967), pp. 526-528
[30.]
C.J. Johns, W.C. Ball.
Steroids in pulmonary parenchymal sarcoidosis with serial measurements of pulmonary function.
La Sarcöidose. Rapports de la IVC Conference Internationale, pp. 742-748
[31.]
C.J. Johns, J.B. Zachary, W.C. Ball.
A ten-year study of corticosteroid treatment of pulmonary sarcoidosis.
Johns Hopkins Med, 134 (1974), pp. 271-283
[32.]
C.S. Johns, M.I. Mc Gregor, J.B. Zachary, W.C. Ball.
Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis. Seventh International Conference on sarcoidosis and other granulomatous disorders.
pp. 722-731
[33.]
D. Böttger.
Results of a controlled therapeutic trial of prednisolone in chronic non-fibrotic pulmonary sarcoidosis. Eight International Conference on sarcoidosis and other granulomatous disease.
pp. 629-631
[34.]
H. Eule, T. Roth, W. Weide.
Clinical and functional results a controlled trial of the value of prednisolone therapy in sarcoidosis, stage I and II.
Eight International Conference on sarcoidosis and other granulomatous diseases, pp. 624-628
[35.]
M. Yamamoto, N. Saito, T. Tachibana, et al.
Effects of 18month corticosteroid therapy on stage I and stage II sarcoidosis patients.
(A controlled trial). Ninth International Conference on sarcoidosis and other granulomatous disorders, pp. 470-474
[36.]
C.J. Johns, S.A. Schonfeld, P.P. Scott, J.B. Zachary, M.I. Mc Gregor.
Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications.
Tenth International Conference on sarcoidosis and other granulomatous disorders, pp. 702-712
[37.]
H. Eule, A. Weinecke, I. Roth, H. Wuthe.
The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Tenth International Conference on sarcoidosis and other granulomatous disorders.
pp. 695-701
[38.]
H. Herzog.
Conclusive summarizing remarks and Outlook.
Sarcoidosis and other granulomatous disorders. C, pp. 385-393
[39.]
B.A. Keogh, J. Bernado, G.W. Hunninghake, D.R. Line, D.L. Price, R.G. Crystal.
Effect of intermittent high dose parentral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis.
Am Rev Respir Dis, 127 (1983), pp. 18-22
[40.]
A.C. Braude, A.S. Rebuck.
Prednisone and methylprednisolone disposition in the lung.
Lancet, 2 (1983), pp. 995-997
[41.]
O. Selroos, T.L. Sellergrent.
Corticosteroid therapy) ol pulmo nary sarcoidosis: a prospective evaluation of alternate day and daily dosage in stage II disease.
Scand J Respir Dis, 60 (1979), pp. 215-221
[42.]
O. Selroos.
Further experiences with inhaled budesonide in the treatment of pulmonary sarcoidosis. Sarcoidosis and other granulomatous disorders.
pp. 637-640
[43.]
J. Lieberman.
The specificity and nature of serum angiotensinconverting enzyme (serum ACE) elevations in sarcoidosis. Seventh International Conference on sarcoidosis and other granulomatous disorders.
pp. 488-497
[44.]
P. Studdy, R. Bird, D.G. James, S. Sherlock.
Serum angiotensinconverting enzyme (SACE) in sarcoidosis and other granulomatous disorders. Eighth International Conference on sarcoidosis and other granulomatous diseases.
pp. 259-265
[45.]
R.H. Winterbauer, J.S. Hutchinson.
Use of pulmonary function test in the management of sarcoidosis.
Chest, 78 (1980), pp. 640-647
[46.]
S.F. Boushy, R.S. Kurtzmann, N.D. Martin, B.M. Lewis.
The course of pulmonary function in sarcoidosis.
Ann Intern Med, 62 (1965), pp. 939-955
[47.]
O.P. Sharma, C. Colp, M.H. Williams Jr..
Course of pulmonary sarcoidosis with and without corticosteroid therapy as determined by. pulmonary function studies.
Amer J Med, 41 (1966), pp. 541-551
[48.]
J. Turiaf, G. Basset, R. Georges.
Prognosis of patients who have been cured of pulmonary sarcoidosis from functional respiratory exploration data.
Poumon Coeur, 25 (1969), pp. 1-15
[49.]
Chapter 17: Treatment Sarcoidosis and other granulomatous disorders.
Major problems in Internal Medicine, pp. 222-232
[50.]
F. Sarcoidosis, J. Badrinas.
Morera.
Ediciones Doyma, (1989),
[51.]
K. Wurm, R. Rosner.
Prognosis of chronic sarcoidosis. Seventh International Conference on sarcoidosis and other granulomatous disorders, pp. 732-735
[52.]
Y. Hosoda, R. Mikami.
International controlled trial of prednisone therapy in pulmonary sarcoidosis. Tenth International Conference on sarcoidosis and other granulomatous disorders.
pp. 692-694
Copyright © 1989. Sociedad Española de Neumología y Cirugía Torácica
